Titlebook: Mastery of IBD Surgery; Neil Hyman,Phillip Fleshner,Scott Strong Book 2019 Springer Nature Switzerland AG 2019 Crohn’s disease.Inflammator

誹謗

Managing Immunomodulators Perioperatively,ise in incidence, there has been a resultant rise in the number of patients on immunosuppressive medications [1]. Colorectal surgeons, therefore, must be well prepared for the potential perioperative complications associated with these medications. Immunomodulators (thiopurines, calcineurin inhibito

跳動

Managing Biologics Perioperatively,g their disease course. Since the advent of biologic therapy with the Federal Drug Administration (FDA) approval of infliximab in 1998, biologics have gained an important foothold in the treatment of inflammatory bowel disease (IBD) [4]. Thus, an ever-increasing number of patients are undergoing sur

lymphedema

Blatant

異常

MUTE

Management of Severe Anoperineal Disease,of patients with anoperineal Crohn’s disease require surgical intervention at some point in their lifetime, and up to 38% of patients with complex perianal fistulas undergo fecal stream diversion. This chapter focuses on surgical treatment of severe perianal Crohn’s disease (pCD) with a goal to comp

圣人

Management of Ano/Rectovaginal Fistula,hroughout this chapter. RVF’s are a devastating problem producing severe symptoms in many cases. They occur more commonly in Crohn’s disease than in the general population, with a prevalence of 10% and mean age of onset of 34?years in a series of 886 patients. A population based survey from Minnesot

和藹

milligram

Management of Isolated Proctitis/Proctosigmoiditis,ic agents or immunosuppressants may require surgical intervention. Nonetheless, there have been few reports about the surgical treatment for isolated proctitis/proctosigmoiditis likely because Crohn’s disease (CD) confined to the rectum or the rectosigmoid colon is a relatively uncommon clinical ent

Wernickes-area

,Role of IPAA for Crohn’s Disease,ormed surgical procedure for patients requiring resection of the entire large intestine provided they demonstrate good sphincter function and lack risk factors for postoperative complications or dysfunction. The operation was initially developed for patients with ulcerative colitis or familial adeno